The roles of neuronal and glial precursors in overcoming chondroitin sulfate proteoglycan inhibition

Experimental Neurology

Volumn 235, Issue 2, 2012, Pages 627-637

  Ketschek, A R ^a   Haas, C ^a   Gallo, G ^a   Fischer, I ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Axon outgrowth; Glial restricted precursors; LAR; Neuronal restricted precursors; Receptor PTP ; Spinal cord injury

Indexed keywords

AGGRECAN; BREVICAN; CD45 ANTIGEN; LAMININ; PROTEIN TYROSINE PHOSPHATASE; PROTEOCHONDROITIN SULFATE; VERSICAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CONTACT; CELL DENSITY; CELL REGENERATION; CELL SURVIVAL; CHICK; CONTROLLED STUDY; CULTURE MEDIUM; EMBRYO; GLIA CELL; GROWTH CONE; NERVE CELL; NERVE FIBER; NERVE FIBER GROWTH; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL; SPINAL CORD INJURY; SPINAL GANGLION; STEM CELL;

ANIMALS; CELLS, CULTURED; CHICK EMBRYO; CHONDROITIN SULFATE PROTEOGLYCANS; COCULTURE TECHNIQUES; NEURAL INHIBITION; NEURAL STEM CELLS; NEUROGLIA; NEURONS; RATS;

EID: 84860365486     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2012.03.017     Document Type: Article

References (44)

1. Afshari F.T., Kwok J.C., White L., Fawcett J.W. Schwann cell migration is integrin-dependent and inhibited by astrocyte-produced aggrecan. Glia 2010, 58:857-869.
2. Blackmore M., Letourneau P.C. Changes within maturing neurons limit axonal regeneration in the developing spinal cord. J. Neurobiol. 2006, 66:348-360.
3. Bonner J.F., Blesch A., Neuhuber B., Fischer I. Promoting directional axon growth from neural progenitors grafted into the injured spinal cord. Neurosci. Res. 2010, 88:1182-1192.
4. Bonner J.F., Connors T.M., Silverman W.F., Kowalski D.P., Lemay M.A., Fischer I. Grafted neural progenitors integrate and restore synaptic connectivity across the injured spinal cord. J. Neurosci. 2011, 31:4675-4686.
5. Borisoff J.F., Pataky D.M., McBride C.B., Steeves J.D. Raphe-spinal neurons display an age-dependent differential capacity for axon outgrowth compared to other brainstem-spinal populations. Exp. Neurol. 2000, 166:16-28.
6. Challacombe J.F., Snow D.M., Letourneau P.C. Dynamic microtubule ends are required for growth cone turning to avoid an inhibitory guidance cue. J. Neurosci. 1997, 17:3085-3095.
7. Coles C.H., Shen Y., Tenney A.P., Siebold C., Sutton G.C., Lu W., Gallagher J.T., Jones E.Y., Flanagan J.G., Aricescu A.R. Proteoglycan-specific molecular switch for RPTPσ clustering and neuronal extension. Science 2011, 332:484-488.
8. Curinga G.M., Snow D.M., Mashburn C., Kohler K., Thobaben R., Caggiano A.O., Smith G.M. Mammalian-produced chondroitinase AC mitigates axon inhibition by chondroitin sulfate proteoglycans. J. Neurochem. 2007, 102:275-288.
9. Davies J.E., Huang C., Proschel C., Noble M., Mayer-Proschel M., Davies S.J. Astrocytes derived from glial-restricted precursors promote spinal cord repair. J. Biol. 2006, 5:7.
10. Dou C.L., Levine J.M. Inhibition of axon growth by the NG2 chondroitin sulfate proteoglycan. J. Neurosci. 1994, 14:7616-7628.
11. Fawcett J.W. The glial response to injury and its role in the inhibition of CNS repair. Adv. Exp. Med. Biol. 2006, 557:11-24.
12. Ferguson T.A., Muir D. MMP-2 and MMP-9 increase the neurite-promoting potential of schwann cell basal laminae and are upregulated in degenerated nerve. Mol. Cell Neurosci. 2000, 16:157-167.
13. Fisher D., Xing B., Dill J., Li H., Hoang H.H., Zhao Z., Yang X.L., Bachoo R., Cannon S., Longo F.M., Sheng M., Silver J., Li S. Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors. J. Neurosci. 2011, 31:14051-14066.
14. Fitch M.T., Silver J. CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure. Exp. Neurol. 2008, 209:294-301.
15. Gomez T.M., Letourneau P.C. Filopodia initiate choices made by sensory neuron growth cones at laminin/fibronectin borders in vitro. J. Neurosci. 1994, 14:5959-5972.
16. Hill C.E., Proschel C., Noble M., Mayer-Proschel M., Gensel J.C., Beattie M.S., Bresnahan J.C. Acute transplantation of glial-restricted precursor cells into spinal cord contusion injuries: survival, differentiation, and effects on lesion environment and axonal regeneration. Exp. Neurol. 2004, 190:289-310.
17. Hynds D.L., Snow D.M. Axon outgrowth inhibition by chondroitin sulfate proteoglycan: stalling/stopping exceeds turning in human neuroblastoma growth cones. Exp. Neurol. 1999, 160:244-255.
18. Hynds D.L., Snow D.M. Fibronectin and laminin elicit differential behaviors from SH-SY5Y growth cones contacting inhibitory chondroitin sulfate proteoglycans. J. Neurosci. Res. 2001, 66:630-642.
19. Jones L.L., Margolis R.U., Tuszynski M.H. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp. Neurol. 2003, 182:399-411.
20. Koprivica V., Cho K.S., Park J.B., Yiu G., Atwal J., Gore B., Kim J.A., Lin E., Tessier-Lavigne M., Chen D.F., He Z. EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans. Science 2005, 310:106-110.
21. Lelkes P.I., Unsworth B.R., Saporta S., Cameron D.F., Gallo G. Culture of Cells for Tissue Engineering, Culture of Neuroendocrine and Neuronal Cells for Tissue Engineering 2006, Wiley, New York, Chap 14. G. Vunjak-Novakovic, R.I. Freshney (Eds.).
22. Lepore A.C., Fischer I. Lineage-restricted neural precursors survive, migrate, and differentiate following transplantation into the injured adult spinal cord. Exp. Neurol. 2005, 194:230-242.
23. Lepore A.C., Han S.S., Tyler-Polsz C.J., Cai J., Rao M.S., Fischer I. Differential fate of multipotent and lineage-restricted neural precursors following transplantation into the adult CNS. Neuron Glia Biol. 2004, 1:113-126.
24. Malla N., Berg E., Uhlin-Hansen L., Winberg J.O. Interaction of pro-matrix metalloproteinase-9/proteoglycan heteromer with gelatin and collagen. J. Biol. Chem. 2008, 283:13652-13665.
25. Matsui F., Oohira A. Proteoglycans and injury of the central nervous system. Congenit. Anom. (Kyoto) 2004, 44:181-188.
26. Properzi F., Asher R.A., Fawcett J.W. Chondroitin sulphate proteoglycans in the central nervous system: changes and synthesis after injury. Biochem. Soc. Trans. 2003, 31:335-336.
27. Properzi F., Carulli D., Asher R.A., Muir E., Camargo L.M., van Kuppevelt T.H., ten Dam G.B., Furukawa Y., Mikami T., Sugahara K., Toida T., Geller H.M., Fawcett J.W. Chondroitin 6-sulphate synthesis is up-regulated in injured CNS, induced by injury-related cytokines and enhanced in axon-growth inhibitory glia. Eur. J. Neurosci. 2005, 21:378-390.
28. Rhodes K.E., Fawcett J.W. Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?. J. Anat. 2004, 204:33-48.
29. Sandvig A., Berry M., Barrett L.B., Butt A., Logan A. Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Glia 2004, 46:225-251.
30. Schlessinger J., Lax I., Lemmon M. Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors?. Cell 1995, 83:357-360.
31. Schmalfeldt M., Bandtlow C.E., Dours-Zimmermann M.T., Winterhalter K.H., Zimmermann D.R. Brain derived versican V2 is a potent inhibitor of axonal growth. J. Cell Sci. 2000, 113:807-816.
32. See J., Bonner J., Neuhuber B., Fischer I. Axon outgrowth of neural progenitors in presence of inhibitory proteoglucans. J. Neurotrauma 2010, 27:951-957.
33. Shen Y., Tenney A.P., Busch S.A., Horn K.P., Cuascut F.X., Liu K., He Z., Silver J., Flanagan J.G. PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science 2009, 326:592-596.
34. Silver J., Miller J.H. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 2004, 5:146-156.
35. Snow D.M., Letourneau P.C. Axon outgrowth on a step gradient of chondroitin sulfate proteoglycan (CS-PG). J. Neurobiol. 1992, 23:322-336.
36. Snow D.M., Mullins N., Hynds D.L. Nervous system-derived chondroitin sulfate proteoglycans regulate growth cone morphology and inhibit axon outgrowth: a light, epifluorescence, and electron microscopy study. Microsc. Res. Tech. 2001, 54:273-286.
37. Snow D.M., Smith J.D., Cunningham A.T., McFarlin J., Goshorn E.C. Axon elongation on chondroitin sulfate proteoglycans is characterized by axonal fasciculation. Exp. Neurol. 2003, 182:310-321.
38. Su Y.K., Elam J.S. Proteoglycan regulation of goldfish retinal explant growth on optic tectal membranes. Brain Res. Dev. Brain Res. 2003, 142:169-175.
39. Tan C.L., Kwok J.C., Patani R., Ffrench-Constant C., Chandran S., Fawcett J.W. Integrin activation promotes axon growth on inhibitory chondroitin sulfate proteoglycans by enhancing integrin signaling. J. Neurosci. 2011, 17:6289-6295.
40. Tom V.J., Steinmetz M.P., Miller J.H., Doller C.M., Silver J. Studies on the development and behavior of the dystrophic growth cone, the hallmark of regeneration failure, in an in vitro model of the glial scar and after spinal cord injury. J. Neurosci. 2004, 24:6531-6539.
41. Winberg J.O., Kolset S.O., Berg E., Uhlin-Hansen L. Macrophages secrete matrix metalloproteinase 9 covalently linked to the core protein of chondroitin sulphate proteoglycans. J. Mol. Biol. 2000, 304:669-680.
42. Yu X., Bellamkonda R.V. Dorsal root ganglia axon extension is inhibited by mechanical and chondroitin sulfate-rich interfaces. J. Neurosci. Res. 2001, 66:303-310.
43. Yu P., Santiago L.Y., Katagiri Y., Geller H.M. Myosin II activity regulates neurite outgrowth and guidance in response to chondroitin sulfate proteoglycans. J. Neurochem. 2011.
44. Zuo J., Ferguson T.A., Hernandez Y.J., Stetler-Stevenson W.G., Muir D. Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan. J. Neurosci. 1998, 18:5203-5211.